Novacyt extends user base into Middle East and secures new patents

Novacyt (Mmemo: ALNOV – FR0010397232) announces the installation of NovaPrep in Kuwait. Download press release

Visit Page

Novacyt secures further funding of up to 5 million euros

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, announces that it has secured flexible bond financing for a maximum of 5 million euros over three years, as part of a private placement underwritten by the YA Global Master SPV Ltd fund. Download press release

Visit Page

Novacyt: Strong First-half Revenues Completes €3.5m in Bond Refinancing and Launches a €1.7m private placement

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, is pleased to report strong first-half sales performance across the Group, the completion of €3.5m in bond refinancing and the launch of a €1.7m private placement of new shares to support the planned growth in the second half of 2015 and into 2016.

Visit Page